Luis García-García Selected Research

Luis García-García Research Topics

Disease

6	Gliosis 01/2019 - 04/2015
4	Status Epilepticus (Complex Partial Status Epilepticus) 12/2021 - 05/2016
4	Seizures (Absence Seizure) 01/2018 - 02/2015
3	Neuroinflammatory Diseases 01/2022 - 01/2012
3	Epilepsy (Aura) 01/2019 - 02/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 05/2022 - 11/2017
2	Catalepsy 05/2022 - 11/2017
2	Amyloidosis 01/2022 - 11/2016
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2018
2	Brain Diseases (Brain Disorder) 01/2019 - 11/2016
2	Alzheimer Disease (Alzheimer's Disease) 11/2016 - 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Insulin Resistance 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Temporal Lobe Epilepsy 09/2017
1	Central Nervous System Tuberculosis 01/2017
1	AIDS-Related Complex (ARC) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 12/2016
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2016
1	Ataxia (Dyssynergia) 12/2016
1	Muscle Weakness 12/2016
1	Dystonia (Limb Dystonia) 12/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 12/2016
1	Ischemic Stroke 08/2015
1	Brain Hypoxia (Cerebral Hypoxia) 08/2015
1	Hypoxia (Hypoxemia) 08/2015
1	Stroke (Strokes) 08/2015
1	Body Weight (Weight, Body) 03/2015
1	Tauopathies 01/2014
1	Body Weight Changes 03/2013
1	Inflammation (Inflammations) 01/2012
1	Hyperphagia (Overeating) 02/2010

Drug/Important Bio-Agent (IBA)

6	Glial Fibrillary Acidic ProteinIBA 05/2022 - 04/2015
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2016
4	Pilocarpine (Ocusert)FDA LinkGeneric 01/2018 - 02/2015
4	LithiumIBA 01/2018 - 02/2015
3	CannabinoidsIBA 01/2019 - 01/2012
3	fluoro-jade CIBA 01/2018 - 04/2015
3	Serotonin (5 Hydroxytryptamine)IBA 05/2016 - 02/2015
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2022 - 11/2017
2	Metyrapone FDA Link 01/2018 - 09/2017
2	EnzymesIBA 01/2018 - 12/2016
2	Neuroprotective AgentsIBA 01/2018 - 01/2017
2	Pharmaceutical PreparationsIBA 11/2017 - 03/2013
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2017 - 02/2010
2	EndocannabinoidsIBA 12/2016 - 11/2016
2	Fluoxetine (Prozac)FDA LinkGeneric 05/2016 - 02/2015
1	Tolcapone (Tasmar)FDA Link 05/2022
1	Levodopa (L Dopa)FDA LinkGeneric 05/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Biological ProductsIBA 01/2022
1	Glycogen Synthase Kinase 3IBA 01/2022
1	Insulin ReceptorIBA 01/2022
1	Technetium Tc 99m Exametazime (Ceretec)FDA Link 12/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	CannabidiolIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2017
1	ropinirole (Requip)FDA LinkGeneric 11/2017
1	GlucocorticoidsIBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	Gatifloxacin (Zymar)FDA Link 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	CorticosteroneIBA 01/2017
1	Polysorbates (PSML)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Caspase 9IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 12/2016
1	anandamide (arachidonylethanolamide)IBA 11/2016
1	pipoxolan (BR 18)IBA 08/2015
1	fluoromisonidazoleIBA 08/2015
1	DAPIIBA 04/2015
1	Appetite Depressants (Anorectics)IBA 03/2015
1	tau Proteins (tau Protein)IBA 01/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	LeptinIBA 02/2010

Therapy/Procedure

1	Therapeutics 01/2019
1	Induced Hyperthermia (Thermotherapy) 01/2017